INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma - Van Den Bent, M; Eoli, M; Sepulveda, J M (Neuro-oncol, 2020)